Uridine phosphorylase - An important enzyme in pyrimidine metabolism and fluoropyrimidine activation

被引:46
作者
Cao, DL [1 ]
Pizzorno, G [1 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med Oncol, Sect Med Oncol, New Haven, CT 06520 USA
关键词
D O I
10.1358/dot.2004.40.5.850491
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Uridine phosphorylase (UPase) is an enzyme that can convert uridine to uracil. Upon the availability of substrates, UPase can also catalyze the formation of nucleosides from uracil or 5-fluorouracil (5-FU) and ribose-1-phosphate (Rib-1-P). UPase gene expression appears featured with the developmental regulation and strictly controlled at promoter level by oncogenes, tumor suppressor genes and cytokines. UPase activity is usually elevated in various tumor tissues, and this induction appears to confer 5-FU therapeutic advantage to cancer patients. UPase is the most important phosphorylase identified up to date in the regulation of uridine homeostasis, although thymidine phosphorylase (TPase) can utilize to a certain extent uridine as a substrate. The modulation of UPase activity by its specific inhibitors such as benzylacyclouridine or the disruption of this gene greatly affects uridine metabolism and pyrimidine nucleotide biosynthesis. UPase also plays an appreciable role in the activation of 5-FU and its prodrug 5'-deoxy-5-fluorouridine (5'DFUR)/capecitabine via anabolism of 5-FU through pyrimidine salvage pathway or the phosphorolysis of 5'DFUR into 5-FU. In this review, we discuss in detail the role of UPase in the regulation of uridine homeostasis and pyrimidine metabolism and in the activation of fluoropyrimidines. To address its potential in cancer treatment, we will also discuss the regulatory mechanisms of UPase gene expression and its induction in tumor tissues. (C) 2004 Prous Science. All rights reserved.
引用
收藏
页码:431 / 443
页数:13
相关论文
共 99 条
[1]   AN UPDATE ON THE BIOCHEMISTRY OF 5-FLUOROURACIL [J].
ARDALAN, B ;
GLAZER, R .
CANCER TREATMENT REVIEWS, 1981, 8 (03) :157-167
[2]  
ARMSTRONG RD, 1983, CANCER CHEMOTH PHARM, V11, P102
[3]  
ARMSTRONG RD, 1980, CANCER RES, V40, P3333
[4]  
AU JLS, 1983, BIOCHEM PHARMACOL, V32, P541
[5]   DETERMINATION OF RIBOSE 1-PHOSPHATE IN ASCITES TUMOR-CELLS [J].
BARANKIEWICZ, J ;
HENDERSON, JF .
BIOCHEMICAL MEDICINE, 1977, 17 (01) :45-53
[6]  
Brown NS, 1998, BIOCHEM J, V334, P1
[7]  
CADMAN EC, 1978, CANCER RES, V38, P682
[8]  
Cao DL, 2002, CANCER RES, V62, P2313
[9]  
Cao DL, 1999, CANCER RES, V59, P4997
[10]   Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells [J].
Chung, YM ;
Park, SH ;
Park, JK ;
Kim, YT ;
Kang, YK ;
Yoo, YD .
CANCER LETTERS, 2000, 159 (01) :95-101